Barriers to Access Do Not Fully Explain Disparities in Ovarian Cancer Treatment
Non-Hispanic Black patients are less likely than Hispanic or non-Hispanic White patients to receive guideline-recommended treatment for ovarian cancer.
Non-Hispanic Black patients are less likely than Hispanic or non-Hispanic White patients to receive guideline-recommended treatment for ovarian cancer.
Breast and prostate cancer mortality rates were higher in AIAN individuals than in White individuals, despite lower incidence rates.
Researchers identified subgroups of patients whose cancer family history information may be unavailable or incomplete.
Though cancer deaths have declined in recent years, the cancer incidence has increased among women and remained stable among men.
From 1999 to 2018, barriers to timely medical care in the United States increased for all racial and ethnic groups.
African-American women who survive breast cancer do not get adequate resources to support their mental and emotional health, a small study suggests.
Black and White patients were similarly likely to be eligible for cancer trials and to be offered enrollment.
From 2005 to 2020, Black women had less access to new mammographic imaging technology compared with White women in the Medicare population.
Cancer patients with barriers to transportation have an increased risk of emergency department visits, cancer-specific mortality, and all-cause mortality, a new study suggests.
Clinical trial eligibility criteria excluded patients due to psychiatric, cognitive or intellectual, visual, hearing, mobility-related, and other disabilities.